PRIMARY EFFUSION LYMPHOMA
Clinical trials for PRIMARY EFFUSION LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY EFFUSION LYMPHOMA trials appear
Sign up with your email to follow new studies for PRIMARY EFFUSION LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune attack on tough cancers: can a combo drug beat the odds?
Disease control OngoingThis study is testing whether adding a new immunotherapy drug (varlilumab) to an existing one (nivolumab) works better than nivolumab alone for patients with aggressive B-cell lymphomas that have come back or stopped responding to standard treatments. The goal is to see if the tw…
Matched conditions: PRIMARY EFFUSION LYMPHOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Researchers dig into old scans to solve a Bone-Weakening puzzle
Knowledge-focused OngoingThis study aims to understand why people with HIV and certain cancers (caused by KSHV virus) often lose bone density, which increases fracture risk. Researchers will analyze existing medical records and CT scans from about 40 patients treated at the NIH between 2005 and 2020. The…
Matched conditions: PRIMARY EFFUSION LYMPHOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC